Difference between revisions of "SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-RASH"
(Imported from text file) |
|||
| Line 2: | Line 2: | ||
1. Acute cutaneous lupus erythematosus (ACLE): erythematous, concentrated on sun exposed areas, malar rash. | 1. Acute cutaneous lupus erythematosus (ACLE): erythematous, concentrated on sun exposed areas, malar rash. | ||
<br/> | <br/> | ||
<br/>2. Subacute cutaneous lupus erythematosus (SCLE): annular rash. Certain meds trigger this rash such as | <br/>2. Subacute cutaneous lupus erythematosus (SCLE): annular rash. Certain meds trigger this rash such as calcium channel blockers. | ||
<br/> | <br/> | ||
<br/>3. Chronic cutaneous lupus erythematosus (CCLE)/discoid lupus erythematosus (OLE): hyperpigmented edges, which may be raised, frequently cause central scarring/atrophy with destruction of melanocytes and hair follicles. | <br/>3. Chronic cutaneous lupus erythematosus (CCLE)/discoid lupus erythematosus (OLE): hyperpigmented edges, which may be raised, frequently cause central scarring/atrophy with destruction of melanocytes and hair follicles. | ||
Revision as of 12:51, 1 January 2023
SUMMARY
1. Acute cutaneous lupus erythematosus (ACLE): erythematous, concentrated on sun exposed areas, malar rash.
2. Subacute cutaneous lupus erythematosus (SCLE): annular rash. Certain meds trigger this rash such as calcium channel blockers.
3. Chronic cutaneous lupus erythematosus (CCLE)/discoid lupus erythematosus (OLE): hyperpigmented edges, which may be raised, frequently cause central scarring/atrophy with destruction of melanocytes and hair follicles.
Reference(s)
Wilkinson, I. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
